Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Invested Capital (2017 - 2025)

Historic Invested Capital for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $534.0 million.

  • Arcus Biosciences' Invested Capital fell 1274.51% to $534.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.0 million, marking a year-over-year decrease of 1274.51%. This contributed to the annual value of $533.0 million for FY2024, which is 1536.8% up from last year.
  • Per Arcus Biosciences' latest filing, its Invested Capital stood at $534.0 million for Q3 2025, which was down 1274.51% from $646.0 million recorded in Q2 2025.
  • Arcus Biosciences' Invested Capital's 5-year high stood at $842.0 million during Q4 2021, with a 5-year trough of $462.0 million in Q4 2023.
  • Moreover, its 5-year median value for Invested Capital was $612.0 million (2024), whereas its average is $628.8 million.
  • Per our database at Business Quant, Arcus Biosciences' Invested Capital surged by 37269.59% in 2021 and then crashed by 2968.04% in 2023.
  • Quarter analysis of 5 years shows Arcus Biosciences' Invested Capital stood at $842.0 million in 2021, then dropped by 21.97% to $657.0 million in 2022, then dropped by 29.68% to $462.0 million in 2023, then increased by 15.37% to $533.0 million in 2024, then increased by 0.19% to $534.0 million in 2025.
  • Its last three reported values are $534.0 million in Q3 2025, $646.0 million for Q2 2025, and $579.0 million during Q1 2025.